The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 62, Issue 10, 2015, Pages 1851-1854

  Badhiwala, Jetan H ^a   Nayiager, Trishana ^b   Athale, Uma H ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER CHILDREN S HOSPITAL   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Acute lymphoblastic leukemia; Oncology; Osteonecrosis; Pediatrics; Thrombosis

Indexed keywords

ASPARAGINASE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; ARTICLE; BONE NECROSIS; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD DISEASE; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOEMBOLISM; ADOLESCENT; COMPLICATION; OSTEONECROSIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; OSTEONECROSIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM;

EID: 84939568668     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25553     Document Type: Article

References (20)

1. Sala A, Mattano LA, Jr., Barr RD. Osteonecrosis in children and adolescents with cancer-an adverse effect of systemic therapy. Eur J Cancer 2007; 43:683-689.
2. te Winkel ML, Pieters R, Hop WC, de Groot-Kruseman HA, Lequin MH, van der Sluis IM, Bokkerink JP, Leeuw JA, Bruin MC, Egeler RM, Veerman AJ, van den Heuvel-Eibrink MM. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. J Clin Oncol 2011; 29:4143-4150.
3. Mattano LA, Jr., Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol 2000; 18:3262-3272.
4. Athale UH, Chan AK. Thrombosis in children with acute lymphoblastic leukemia: part I. Epidemiology of thrombosis in children with acute lymphoblastic leukemia. Thromb Res 2003; 111:125-131.
5. Glueck CJ, Freiberg RA, Boppana S, Wang P. Thrombophilia, hypofibrinolysis, the eNOS T-786C polymorphism, and multifocal osteonecrosis. J Bone Joint Surg Am 2008; 90:2220-2229.
6. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002; 32:94-124.
7. Athale UH, Chan AK. Thrombosis in children with acute lymphoblastic leukemia. Part II. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of the disease and therapy. Thromb Res 2003; 111:199-212.
8. Athale U, Siciliano S, Thabane L, Pai N, Cox S, Lathia A, Khan A, Armstrong A, Chan AK. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer. Pediatr Blood Cancer 2008; 51:792-797.
9. Tuckuviene R, Christensen AL, Chan AK, Athale U. Body mass index and thromboembolism in children with hematological malignancies. Pediatr Blood Cancer 2012; 59:320-322.
10. Kawedia JD, Kaste SC, Pei D, Panetta JC, Cai X, Cheng C, Neale G, Howard SC, Evans WE, Pui CH, Relling MV. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood 2011; 117:2340-2347. quiz 2556.
11. Niinimaki RA, Harila-Saari AH, Jartti AE, Seuri RM, Riikonen PV, Paakko EL, Mottonen MI, Lanning M. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia. J Clin Oncol 2007; 25:1498-1504.
12. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL. CDC growth charts: United States. Adv Data 2000; 314:1-27.
13. Kerachian MA, Harvey EJ, Cournoyer D, Chow TY, Seguin C. A vascular necrosis of the femoral head: vascular hypotheses. Endothelium 2006; 13:237-244.
14. Glueck CJ, Freiberg RA, Boriel G, Khan Z, Brar A, Padda J, Wang P. The role of the factor V leiden mutation in osteonecrosis of the hip. Clin Appl Thromb Hemost 2013; 19:499-503.
15. Bjorkman A, Svensson PJ, Hillarp A, Burtscher IM, Runow A, Benoni G. Factor V leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults. Clin Orthop Relat Res 2004; 425:168-172.
16. Zalavras CG, Malizos KN, Dokou E, Vartholomatos G. The 677C->T mutation of the methylene-tetrahydrofolate reductase gene in the pathogenesis of osteonecrosis of the femoral head. Haematologica 2002; 87:111-112.
17. Kim H, Cho C, Cho Y, Cho S, Yoon K, Kim K. Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head. BMC Musculoskelet Disord 2011; 12:160.
18. Koo KH, Lee JS, Lee YJ, Kim KJ, Yoo JJ, Kim HJ. Endothelial nitric oxide synthase gene polymorphisms in patients with nontraumatic femoral head osteonecrosis. J Orthop Res 2006; 24:1722-1728.
19. French D, Hamilton LH, Mattano LA, Jr., Sather HN, Devidas M, Nachman JB, Relling MV. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 2008; 111:4496-4499.
20. te Winkel ML, Appel IM, Pieters R, van den Heuvel-Eibrink MM. Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia. Haematologica 2008; 93:1570-1574.